Summarize this content to 2000 words in 6 paragraphs
Xealth CEO Mike McSherry. (GeekWire Photo)
Seattle health tech startup Xealth today announced new funding from Morningside Ventures. The investment will help the company’s development of its digital healthcare delivery platform.
Xealth did not disclose the amount invested by Morningside, a Boston-area firm that backs digital health startups. In 2021 Xealth shared news of a $24 million Series B round led by Advocate Aurora Enterprises. Its total funding to date at the time was $52.4 million.
Xealth enables health providers to access and monitor tools including remote patient monitoring devices, health questionnaires, prescription services and traditional smartphone apps.
The startup integrates its services with electronic health care records so patients can share information directly with providers. Providers, in turn, can gain insight into the tools’ performance with patients. Xealth partners with the country’s largest electronic health record vendors.
The startup makes money by licensing its platform to hospital systems and offers services from more than 50 digital health vendors.
Xealth said it has worked with 100,000 medical providers and facilitated the transmission of 12 million orders.
The company launched in 2017 when it spun out of Providence, a multi-state healthcare network based in Renton, Wash., that serves patients in Washington, Oregon, California, Alaska, Montana, New Mexico and Texas. The Catholic organization is one of the largest nonprofit healthcare providers in the country.
Xealth is led by CEO Mike McSherry, who previously led Swype, which sold to Nuance for $100 million in 2011. The company has 55 employees.
Xealth’s competitors include Redox and Health Gorilla.
